Form 8-K OncoMed Pharmaceuticals For: May 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
OncoMed Pharma (OMED) Misses Q1 EPS by 14c
May 7, 2015 4:56 PM EDTOncoMed Pharma (NASDAQ: OMED) reported Q1 EPS of ($0.49), $0.14 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $15.35 million.
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
... More